257
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles

, , , , , & show all
Pages 1792-1800 | Received 01 Apr 2017, Accepted 24 May 2017, Published online: 21 Jun 2017

References

  • Esko JD, Kimata K, Lindahl U, Proteoglycans and sulfated glycosaminoglycans. In: Varki A, Cummings R, Esko J, et al., editors. Essentials of glycobiology. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 2009.
  • Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006;85:699–715.
  • Calleja-Agius J, Brincat M, Borg M. Skin connective tissue and ageing. Best Pract Res Clin Obstet Gynaecol. 2013;27:727–740.
  • Cerimele D, Del Forno C, Serri F. Histochemistry of the intercellular substance of the normal and psoriatic human epidermis. Archives for Dermatological Research Archiv Fur Dermatologische Forschung 1978;262:27–36.
  • Sakai S, Yasuda R, Sayo T, et al. Hyaluronan exists in the normal stratum corneum. J Invest Dermatol. 2000;114:1184–1187.
  • Hudson DL, Sleeman J, Watt FM. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci. 1995;108:1959–1970.
  • Weindl G, Schaller M, Schäfer-Korting M, et al. Hyaluronic acid in the treatment and prevention of skin diseases: Molecular biological, pharmaceutical and clinical aspects. 2004;17:207–213.
  • Adzick NS, Longaker MT. Scarless fetal healing. Therapeutic implications. Ann Surg. 1992;215:3–7.
  • Sayo T, Sakai S, Inoue S. Synergistic effect of N-acetylglucosamine and retinoids on hyaluronan production in human keratinocytes. Skin Pharmacol Physiol. 2004;17:77–83.
  • Tu CX, Zhang RX, Zhang XJ, et al. Exogenous N-acetylglucosamine increases hyaluronan production in cultured human dermal fibroblasts. Arch Dermatol Res. 2009;301:549–551.
  • Chen JK, Shen CR, Liu CL. N-acetylglucosamine: production and applications. Mar Drugs. 2010;8:2493–2516.
  • Pedrali A, Bleve M, Capra P, et al. Determination of N-acetylglucosamine in cosmetic formulations and skin test samples by hydrophilic interaction liquid chromatography and UV detection. J Pharm Biomed Anal. 2015; 3/25/107:125–130.
  • Bissett DL, Robinson LR, Raleigh PS, et al. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol. 2007;6:20–26.
  • Kimball AB, Kaczvinsky JR, Li J, et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br J Dermatol. 2010;162:435–441.
  • Tzoumaki MV, Moschakis T, Kiosseoglou V, et al. Oil-in-water emulsions stabilized by chitin nanocrystal particles. Food Hydrocoll. 2011; 8//25:1521–1529.
  • Virkutyte J, Varma RS. Green synthesis of metal nanoparticles: Biodegradable polymers and enzymes in stabilization and surface functionalization. Chem Sci. [10.1039/C0SC00338G]. 2011;2:837–846.
  • Mancini G, Lopes RM, Clemente P, et al. Lecithin and parabens play a crucial role in tripalmitin‐based lipid nanoparticle stabilization throughout moist heat sterilization and freeze‐drying. Eur J Lipid Sci Technol. 2015;117:1947–1959.
  • Ramasamy T, Khandasami US, Ruttala H, et al. Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent. Macromol Res. 2012;20:682–692.
  • Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170–184.
  • Vitorino C, Almeida J, Gonçalves LM, et al. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. J Controlled Release. 2013; 5/10/167:301–314.
  • Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002; 11/1/54, Supplement(0):S131–SS55.
  • Souto E, Almeida A, Müller R, editors. SLN and NLC as viscoelastic enhancers for topical drug delivery. Proceeding XIV international workshop on bioencapsulation & COST 865 meeting (Lausanne, Switzerland) O6-5; 2006.
  • Dingler A, Gohla S. Production of solid lipid nanoparticles (SLN): scaling up feasibilities. J Microencapsul. 2002;19:11–16.
  • Malaekeh-Nikouei B, Golmohammadzadeh S, Salmani-Chamanabad S, et al. Preparation, characterization, and moisturizing effect of liposomes containing glucosamine and N-acetyl glucosamine. J Cosmet Dermatol. 2013;12:96–102.
  • Negrulescu A, Patrulea V, Mincea MM, et al. Adapting the reducing sugars method with dinitrosalicylic acid to microtiter plates and microwave heating. J Braz Chem Soc. 2012;23:2176–2182.
  • Andre P. Hyaluronic acid and its use as a “rejuvenation” agent in cosmetic dermatology. Semin Cutan Med Surg. 2004;23:218–222.
  • Aliasgharlou L, Ghanbarzadeh S, Azimi H, et al. Nanostructured lipid carrier for topical application of N-acetyl glucosamine. Adv Pharm Bull. 2016;6:581–587.
  • Stone HA. Dynamics of drop deformation and breakup in viscous fluids. Annu Rev Fluid Mech. 1994;26:65–102.
  • Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine. 2007;2:289.
  • Müller RH, Petersen RD, Hommoss A, et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59:522–530.
  • Arora ASS. Development of topical gel of capsaicin loaded solid lipid nanoparticles (SLNs): in vitro and in vivo evaluation. Ind J Pharm. 2011;2:29–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.